Eight months after reaching its goal of becoming entirely consumer health-focused, Perrigo Company PLC checks another box on its list with approval of its first national brand OTC product, Nasonex 24HR Allergy.
Nasonex 24HR Allergy also will be the first nonprescription mometasone furoate product available in the US. It will compete in...







